In this webinar, we will investigate if brain atrophy could be used as a biomarker of the disease that can resolve the clinico-radiological paradox and predict the outcome.
Grey Matter Atrophy in MS
Feb 16th, 2022Dec 31st, 1969
Latest in Home
Dublin team evaluates radiation dose in PSMA PET/CT
July 18, 2025
Assessing CT image quality: Which method is best?
July 16, 2025
CT pearls from Ireland’s top orthopedic hospital
July 15, 2025